- Home
- AEON vs NDRA Comparison
AEON vs NDRA Comparison
Compare AEON & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEON | NDRA |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 8.1M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | AEON | NDRA |
|---|---|---|
| Price | $0.26 | $5.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.20 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 10.0M | 43.5K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $2.96 |
| 52 Week High | $1.45 | $9.83 |
Technical Indicators
Market Signals| Indicator | AEON | NDRA |
|---|---|---|
| Relative Strength Index (RSI) | 47.89 | 62.33 |
| Support Level | $0.26 | $4.49 |
| Resistance Level | $0.33 | $6.35 |
| Average True Range (ATR) | 0.04 | 0.66 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 34.34 | 76.73 |
Price Performance
Historical ComparisonAbout AEON AEON Biopharma Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.